Pantoprazole Stada

Pantoprazole, the active ingredient in Pantoprazole Stada, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and other acid‑related disorders in adults. GNH USA supplies Pantoprazole Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazole Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton‑pump inhibitor that acts on gastric acid secretion pathways. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): Improves heart‑burn symptoms and promotes healing of the oesophageal lining. - Erosive esophagitis: Facilitates healing of erosions and ulcers in the oesophagus. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production associated with this rare endocrine disorder. - Peptic ulcer disease (duodenal and gastric ulcers): Supports ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication regimens (as part of combination therapy): Enhances eradication success when used with antibiotics. - NSAID‑induced ulcer prophylaxis: Lowers ulcer risk in patients requiring long‑term non‑steroidal anti‑inflammatory drug therapy.

Pantoprazole is generally well tolerated, but like all medicines it can cause adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or vomiting: occasional gastrointestinal upset. - Abdominal pain or discomfort: mild cramping. - Flatulence: increased gas production. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: signs of hepatitis. - Acute interstitial nephritis: kidney inflammation.

Before starting Pantoprazole, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review liver health: monitor if hepatic disease is present. - Evaluate need for long‑term therapy: prolonged use may increase fracture risk. - Check for potential drug interactions: especially with antiplatelet agents and certain antivirals. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring more frequent monitoring. - Methotrexate: reduced renal clearance may raise toxicity risk. - Digoxin: higher serum levels possible, monitor cardiac function. - Oral contraceptives: slight reduction in efficacy, advise backup contraception.